Skip to main content

Laura Jean Havrilesky

Professor of Obstetrics and Gynecology
Obstetrics and Gynecology, Gynecologic Oncology
Box 3079 Med Ctr, Durham, NC 27710
25172 Morris Bldg, Durham, NC 27710

Research Interests


I am a gynecologic oncologist with an interest in health outcomes and patient preferences. My group has performed several prospective studies of patient preferences regarding the side effects of chemotherapy, surgery, and radiation therapy treatments for ovarian and cervical cancer.  We have developed a number of health outcomes models to inform decisions related to gynecologic cancers, including screening, diagnostic testing, and treatment decisions for endometrial, cervical, and ovarian cancer. I currently serve on NRG Oncology’s Patient Centered Outcomes Research Committee and am co-chair of the Comparative Effectiveness Subcommittee for the NRG. 

Selected Grants


Duke Women's Reproductive Health Research Scholars

Inst. Training Prgm or CMEMentor · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2030

TDAN - Tissue and Data Acquisition Network

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2025 - 2026

Comparative Modeling for the Prevention and Control of Uterine Cancer

ResearchPrincipal Investigator · Awarded by Columbia University · 2021 - 2026

Gynecological Cancer Center of Excellence (GYN-COE) Tissue and Data Acquisition Network (TDAN) with Duke University

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2024 - 2024

Gynecological Cancer Center of Excellence (GYN-COE) Tissue and Data Acquisition Network (TDAN) with Duke University

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2022 - 2024

Tissue and Data Acquisition Activity for the Study of Gynecologic Disease

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2016 - 2022

Intraluminal tumor cells and endometrial cancer prognosis

ResearchPrincipal Investigator · Awarded by Ohio State University · 2020 - 2021

Cancer Tx with a PARP Inhibitor VS Standard

ResearchCo Investigator · Awarded by TESARO · 2017 - 2020

Women with BRCA-mutated Advanced Stage Ovarian Cancer

ResearchPrincipal Investigator · Awarded by AstraZeneca LP · 2017 - 2019

Assessing the relevance of weighted values in the ASCO value framework in ovarian cancer patients

ResearchPrincipal Investigator · Awarded by Gynecologic Oncology Group · 2016 - 2017

Tissue and Data Acquisition Activity for the Study of Gynecologic Disease

ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2016 - 2017

Ovarian Cancer Patient-Centered Decision Aid

ResearchPrincipal Investigator · Awarded by University of California - Irvine · 2013 - 2016

A Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope with Disease Recurrence

ResearchCo Investigator · Awarded by Foundation for Women's Cancer · 2014 - 2016

Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2010 - 2012

Tissue and Data Acquisition Activity for the Study of Gynecologic Disease

ResearchPrincipal Investigator · Awarded by United States Army Medical Research and Materiel Command · 2010 - 2011

Decision Analysis on Screening for Cervical Cancer

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2007 - 2008

Genomics Tests for Ovarian Cancer Detection and Management

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2005 - 2006

Management of Adnexal Mass

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2004 - 2006